Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
企業コードSRTS
会社名Sensus Healthcare Inc
上場日Jun 03, 2016
最高経営責任者「CEO」Mr. Joseph C. Sardano
従業員数35
証券種類Ordinary Share
決算期末Jun 03
本社所在地851 Broken Sound Pkwy NW Ste 215
都市BOCA RATON
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号33487-3635
電話番号15619225808
ウェブサイトhttps://sensushealthcare.com/
企業コードSRTS
上場日Jun 03, 2016
最高経営責任者「CEO」Mr. Joseph C. Sardano
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし